BSX · 8-K · 20261028PR000066
Market Demand Trends
BOSTON SCIENTIFIC CORP · 2026-10-28 · Importance 30 · Surprise 40 · In source text
Third-quarter 2026 net sales in the Neuromodulation business grew 13.1% reported and 13.0% operational and organic year over year, exceeding the 10% materiality threshold. The company reported that the growth rates for Endoscopy and Urology were declines of 0.6% and 3.2%, respectively, while MedSurg grew 0.7% operationally and organically. Cardiovascular net sales grew 1.9% on reported, operational and organic bases.
Key facts
- Boston Scientific disclosed that a cybersecurity incident was first reported on August 26, 2026, and that disruptions from it could affect operations and financial results. source
- Boston Scientific said its global teams responded to the cybersecurity incident with urgency to restore operations and continue supporting customers and patients. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | contingent | — | Boston Scientific disclosed that a cybersecurity incident was first reported on August 26, 2026, and that disruptions from it could affect… |